Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis.
about
Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor modelLoss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivationDominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survivalMechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastomaSesterterpenoids with Anticancer ActivitySmall-molecule agonists of mammalian Diaphanous-related (mDia) formins reveal an effective glioblastoma anti-invasion strategy.Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressivenessFibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasionInhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathwaysAutophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cellsMicheliolide derivative DMAMCL inhibits glioma cell growth in vitro and in vivoQuantitative Analysis of the Cellular Microenvironment of Glioblastoma to Develop Predictive Statistical Models of Overall Survival.Pigment Epithelium-Derived Factor (PEDF) Expression Induced by EGFRvIII Promotes Self-renewal and Tumor Progression of Glioma Stem Cells.Acoustically enhanced Evans blue dye perfusion in neurological tissues.CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance.JLK1486, a Bis 8-Hydroxyquinoline-Substituted Benzylamine, Displays Cytostatic Effects in Experimental Gliomas through MyT1 and STAT1 Activation and, to a Lesser Extent, PPARγ ActivationA chalcone-related small molecule that induces methuosis, a novel form of non-apoptotic cell death, in glioblastoma cells.Four individually druggable MET hotspots mediate HGF-driven tumor progression.Present and potential future issues in glioblastoma treatment.Involvement of mitochondrial aggregation in arsenic trioxide (As2O3)-induced apoptosis in human glioblastoma cells.Possible novel therapy for malignant gliomas with secretable trimeric TRAIL.NHERF-1: modulator of glioblastoma cell migration and invasionTherapeutic strategies for inhibiting invasion in glioblastoma.Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme.Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cells.Galectins and gliomas.Akt inhibitors: mechanism of action and implications for anticancer therapeutics.The lectin concanavalin-A signals MT1-MMP catalytic independent induction of COX-2 through an IKKgamma/NF-kappaB-dependent pathway.αB-crystallin is elevated in highly infiltrative apoptosis-resistant glioblastoma cells.Shifting the optimal stiffness for cell migrationThe potential roles of aquaporin 4 in malignant gliomasMultiphoton imaging of actin filament formation and mitochondrial energetics of human ACBT gliomas.Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression LevelCytotoxic autophagy in cancer therapy.DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression.Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartmentsBiology, genetics and imaging of glial cell tumours
P2860
Q21133610-5912ECBA-4D9B-4ABD-82D2-51CEC7F80042Q24297357-A73599EE-FC96-4EE0-BC3D-50BA78AD1BC4Q24546291-4283CD93-982C-4F72-B11C-F04C59A389CBQ24607424-B4BA1677-E476-4AC5-8F0E-AD865E766E2BQ26795736-A180676B-454F-4421-9702-AD62AA5A9B8BQ27306686-4EB79690-CD90-48B4-B108-57BC6BAEAADDQ28247786-F639FD41-045E-4413-A2C0-0748C2E59806Q28263549-442E333A-CBB9-455B-8DCE-92451DA92671Q28286344-C5974BEF-FA47-43A3-A4DC-5A8B56604025Q28478548-92F96D18-E6B9-4D04-B6A2-E5D464E6C297Q28543364-15126885-6E7D-4DE6-A9B8-4FBCF1ED05F9Q30275479-1A19D6B2-1D95-46C7-8C52-B13562AE99ECQ30393905-A0637A81-9D3D-4A92-AEE3-B41780195B02Q30477981-92CE5BBE-F7F8-402A-AC85-FA7F5E7B8353Q30500172-F74B986D-28E6-43E5-B2F6-C199A8DD9089Q30500762-04D1A453-0CDF-4547-B6CB-294FAC4175DDQ30501296-FC96C278-8860-44A1-ADFE-DD8BC5990114Q30581656-46B06715-DB61-43AA-AE88-1E99D3B6A2FBQ31043603-96112909-4E74-4359-BCFA-596074CEC9B1Q33226642-1737A83F-0A97-4DD7-8F5D-714D692FC45CQ33410831-56946558-3A81-4487-8CF5-D321D617A34DQ33420852-B75068DF-F357-4343-A508-F279362AAF79Q33426563-23E7A778-7040-466C-BF94-B78A688381C2Q33518926-690C8D0D-22C6-4E4D-9C5F-E874695F7D0DQ33588193-54CEB7FB-0044-4C4D-B6E5-BCDF87450EA9Q33588438-44862883-0823-4154-80B3-657CBE2B5D1DQ33641026-9881C136-EBDD-4961-B6E2-9811C6F51DAEQ33651146-A4C0095D-33EA-464C-94C9-1D49F0462628Q33683216-BAC64A4C-9E8B-455A-8342-0F33EAED7DB0Q33761408-AA0DA983-A2CC-4A43-9704-9890945179F1Q33762106-AAAE9218-50B5-4E0F-A5E9-6DF41C3B04F0Q33766496-729F10E5-E8FE-4136-84F6-C545DF35400DQ33828114-41DF1805-C8AC-4961-835D-BEA3046D22F2Q33834080-2E842997-A5EF-4DDD-9483-2FF2FDBCBBD9Q33874532-4AABE256-D666-45FB-90BD-0D52092229DFQ33907663-13D130BC-41CB-47C6-8E06-335CE885ECA0Q33939106-036EEFE3-5636-4BC8-BB00-906723E59255Q34105361-2F5274FE-8D05-4210-85C7-B3D23249C7ABQ34194782-FBE305A8-426D-4D27-8AFC-BC06D8CDF759Q34203979-686FADED-FE9E-4348-B9DF-238D310908E6
P2860
Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Possible future issues in the ...... ioblastoma cells to apoptosis.
@ast
Possible future issues in the ...... ioblastoma cells to apoptosis.
@en
type
label
Possible future issues in the ...... ioblastoma cells to apoptosis.
@ast
Possible future issues in the ...... ioblastoma cells to apoptosis.
@en
prefLabel
Possible future issues in the ...... ioblastoma cells to apoptosis.
@ast
Possible future issues in the ...... ioblastoma cells to apoptosis.
@en
P2093
P356
P1476
Possible future issues in the ...... ioblastoma cells to apoptosis.
@en
P2093
Florence Lefranc
Jacques Brotchi
Robert Kiss
P304
P356
10.1200/JCO.2005.03.089
P407
P577
2005-04-01T00:00:00Z